The estimated Net Worth of Javier Rodriguez is at least $179 Million dollars as of 26 August 2024. Mr. Rodriguez owns over 40,119 units of DaVita Inc stock worth over $138,239,287 and over the last 17 years he sold DVA stock worth over $23,535,372. In addition, he makes $16,853,500 as Chief Executive Officer and Director at DaVita Inc.
Sign up
Mr. Rodriguez DVA stock SEC Form 4 insiders trading
Javier has made over 40 trades of the DaVita Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently he sold 40,119 units of DVA stock worth $6,255,756 on 26 August 2024.
The largest trade he's ever made was exercising 750,000 units of DaVita Inc stock on 20 August 2024 worth over $50,850,000. On average, Javier trades about 71,550 units every 91 days since 2007. As of 26 August 2024 he still owns at least 897,716 units of DaVita Inc stock.
You can see the complete history of Mr. Rodriguez stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Javier Rodriguez biography
Javier J. Rodriguez serves as Chief Executive Officer, Director of the Company. From March 2014 until June 2019, he served as the CEO of DaVita Kidney Care. Since joining the Company in 1998, Mr. Rodriguez has served in a number of different capacities. From February 2012 to March 2014, he served as our President. From April 2006 through February 2012, he served as our Senior Vice President. Before that, from 2000 to 2006 he served as a Vice President of Operations and Payor Contracting. Mr. Rodriguez joined the Company in 1998 as a Director of Value Management. Prior to joining the Company, Mr. Rodriguez worked for Baxter Healthcare Corporation in Finance from 1995 to 1996. He also previously served as Director of Operations for CBS Marketing Inc. in Mexico City. Mr. Rodriguez provides extensive knowledge of our industry, business, regulatory environment and operations as well as significant executive leadership and management experience.
What is the salary of Javier Rodriguez?
As the Chief Executive Officer and Director of DaVita Inc, the total compensation of Javier Rodriguez at DaVita Inc is $16,853,500. There are no executives at DaVita Inc getting paid more.
How old is Javier Rodriguez?
Javier Rodriguez is 49, he's been the Chief Executive Officer and Director of DaVita Inc since 2019. There are 16 older and 3 younger executives at DaVita Inc. The oldest executive at DaVita Inc is John Nehra, 71, who is the Independent Director.
What's Javier Rodriguez's mailing address?
Javier's mailing address filed with the SEC is C/O DAVITA INC., 2000 16TH STREET, DENVER, CO, 80202.
Insiders trading at DaVita Inc
Over the last 22 years, insiders at DaVita Inc have traded over $539,813,199 worth of DaVita Inc stock and bought 20,841,023 units worth $1,590,012,094 . The most active insiders traders include Hathaway Incbuffett Warren ..., R. Ted Weschler,, and Kent J Thiry. On average, DaVita Inc executives and independent directors trade stock every 12 days with the average trade being worth of $12,626,872. The most recent stock trade was executed by Kathleen Alyce Waters on 28 August 2024, trading 26,333 units of DVA stock currently worth $1,999,991.
What does DaVita Inc do?
about davita kidney care davita kidney care is a division of davita healthcare partners inc., a fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the united states and abroad. a leading provider of dialysis services in the united states, davita kidney care treats patients with chronic kidney failure and end stage renal disease. davita kidney care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. as of march 31, 2015, davita kidney care operated or provided administrative services at 2,197 outpatient dialysis centers located in the united states serving approximately 174,000 patients. the company also operated 93 outpatient dialysis centers located in 10 countries outside the united states. davita kidney care supports numerous programs dedicated to creating positive,
What does DaVita Inc's logo look like?
Complete history of Mr. Rodriguez stock trades at Gilead Sciences and DaVita Inc
DaVita Inc executives and stock owners
DaVita Inc executives and other stock owners filed with the SEC include:
-
Javier Rodriguez,
Chief Executive Officer, Director -
Joel Ackerman,
Chief Financial Officer, Treasurer -
Charles Berg,
Director -
Kathleen Waters,
Chief Legal Officer -
Javier J. Rodriguez,
CEO & Exec. Director -
LeAnne Zumwalt,
Group Vice President, Government Affairs -
Michael David Staffieri,
Chief Operating Officer of Kidney Care -
Joel Ackerman,
CFO & Treasurer -
Kathleen Alyce Waters,
Chief Legal and Public Affairs Officer -
James O. Hearty,
Chief Compliance Officer -
Barbara Desoer,
Independent Director -
Pascal Desroches,
Independent Director -
Pamela Arway,
Independent Chairman of the Board -
John Nehra,
Independent Director -
Paul Diaz,
Independent Director -
Phyllis Yale,
Independent Director -
Jim Gustafson,
Vice President - Investor Relations -
Paula Price,
Independent Director -
Shawn Guertin,
Director -
Kenny Gardner,
Chief People Officer - DaVita Kidney Care -
James Hearty,
Chief Compliance Officer -
John Winstel,
Chief Accounting Officer -
Kenneth Gardner Smith,
Chief People Officer -
Kenny Gardner,
Chief People Officer -
Atul Mathur,
Exec. VP of Global Operations -
Bill Myers,
VP of Marketing & Communications -
John D. Winstel,
Chief Accounting Officer -
Jeanine Marie Jiganti,
Chief Compliance Officer -
Peter T Grauer,
Director -
James K Hilger,
Vice President and Controller -
William L Roper,
Director -
Carol Anthony Davidson,
Director -
Roger Valine,
Director -
Joseph C Mello,
Chief Operations Officer -
Allen Nissenson,
Chief Medical Officer -
Dennis W Pullin,
Director -
R. Ted Weschler,,
-
Hathaway Incbuffett Warren ...,
-
Robert J Margolis,
Co-Chairman of the Board -
Laura Mildenberger,
SVP & Chief People Officer -
Kim M Rivera,
VP, Gen. Counsel & Secretary -
Dennis Kogod,
President - West -
Garry E Menzel,
Senior Vice President, Finance -
David T Shapiro,
Chief Compliance Officer -
Charles J Mcallister,
Chief Medical Officer -
Steven J Udicious,
V.P., Sec. and Gen. Counsel -
Joseph Schohl,
VP, Secretary & Gen. Counsel -
Willard Woodson Jr Brittain,
Director -
Nancy Ann Deparle,
Director -
Mary Kowenhoven,
Vice President - Strategy -
Thomas O Usilton,
Group Vice President -
Patricia Jones,
Chief People Officer -
C Raymond Jr Larkin,
Director -
Christopher J Riopelle,
Chief Compliance Officer -
Thomas L Kelly,
Executive Vice President -
Luis Borgen,
Chief Financial Officer -
Georgina Randolph,
Senior Vice President -
Richard B Fontaine,
Director -
Mark G Harrison,
Chief Financial Officer -
Richard K Whitney,
Chief Financial Officer -
Richard C Vaughan,
Director -
Gary Beil,
Vice President and Controller -
Patrick A Broderick,
VP, Secretary & Gen. Counsel -
Lori Richardson Pelliccioni,
Cheif Compliance Officer -
Michele J Hooper,
Director -
Michael David Staffieri,
Chief Operating Officer, DKC -
Kent J Thiry,
Executive Chairman -
Gregory J. Moore,
Director -
Jason M. Hollar,
Director -
Adam H Schechter,
Director -
Christopher Michael Berry,
Chief Accounting Officer -
Wendy Lee Schoppert,
Director